Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A3363 DGAT-1 inhibitorSummary: Diacylglycerol acyltransferase (DGAT1) inhibitor
-
A3542 LCQ-908Summary: DGAT1 inhibitor
-
A3215 AZD7687Target: DGATSummary: DGAT inhibitor,potent and selective
-
C4872 Amidepsine ASummary: DGAT inhibitor
-
C4875 Amidepsine DSummary: DGAT inhibitor
-
B4944 AZD 3988Summary: diacylglycerol acyltransferase (DGAT-1) inhibitor